Zachary Brennan from in-pharmatechnologist.com covered FDA’s plan to increase foreign facility inspections. FDA has made inspecting high-risk firms a top priority not just in the United States but also overseas. This is not new for FDA as they planned on visiting 750 high-risk firms in 2013,  but they were actually able to visit 808. Out of those 808 visited, 43 warning letters were issued. To read the full article click here.